Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.


TSX:MBX - Post by User

Comment by Mbxwatcheron Dec 01, 2022 3:18pm
146 Views
Post# 35144108

RE:RE:RE:RE:Unbelievable

RE:RE:RE:RE:Unbelievable It would be comforting to see some insiders buying at these levels.  We have not seen that in a while.
I think they are loaded up with stock options, and dont need to buy on the open market........

However, it was a comforting signal when they were doing that.

I think this year its been the opposite....selling on the open market and buying .23 options.

Anyway, there really isnt much to left to say..

I suspect Q4 was a 'miss'  In listening to Cameron, he basically said that not every quarter would be a record (or something like that), and the odd miss is to be expected.  The fact that the miss comes in what was projected to be a 'transformative' quarter is dissapointing.

I think we were all expecting bigger numbers from VTM, and the fact that there seems to have been no measureable progress on other customers yet is dissapointing.

Finally, we are behind schedule on QAPS agreements, and I believe that we all expected more of them to be signed by now....Without assigning blame for that, it is dissapointing.

Therefore all these signals plus a difficult market, translates to what we are seeing in the share price.  All is not lost for sure, and we have a longer term tremendous buying opportunity right now if we believe that they will deliver on this............Kinlytic is icing on the cake.  

If we are honest with ourselves we have seen this or something like it coming for months.   Im long so havent sold a share, and will buy more in the new year.
<< Previous
Bullboard Posts
Next >>